Comparison of Monoamine Oxidase A in Peripheral Organs in Nonsmokers and Smokers
Joanna S. Fowler, PhD1,
Jean Logan, PhD1,
Gene-Jack Wang, MD2,
Nora D. Volkow, MD3,
Frank Telang, MD2,
Wei Zhu, PhD4,
Dinko Franceschi, MD5,
Colleen Shea, MS1,
Victor Garza, MS1,
Youwen Xu, MS1,
Yu-Shin Ding, PhD1,
David Alexoff, BSE1,
Donald Warner1,
Noelwah Netusil, RN2,
Pauline Carter, RN2,
Millard Jayne, RN2,
Payton King, MS2 and
Paul Vaska, PhD2
1 Chemistry Department, Brookhaven National Laboratory, Upton, New York
2 Medical Department, Brookhaven National Laboratory, Upton, New York
3 National Institute on Drug Abuse, Bethesda, Maryland
4 Department of Applied Mathematics and Statistics, State University of New York at Stony Brook, Stony Brook, New York
5 Department of Radiology, State University of New York at Stony Brook, Stony Brook, New York

View larger version (10K):
[in a new window]
|
FIGURE 1. Structures of 11C-clorgyline and 11C-clorgyline-D2. The CH (CD) bond in the methylene carbon of the propargyl group is the one that is cleaved in the rate-contributing step of MAO-catalyzed oxidation.
|
|

View larger version (19K):
[in a new window]
|
FIGURE 2. Timeactivity curves for nonsmokers and smokers for 11C-clorgyline for arterial plasma for the first 5 min after injection corrected for the presence of labeled metabolites (A) and for lungs over a 52-min experimental period (B). Note that smokers have reduced arterial input as well as slower lung clearance of 11C. A similar pattern is seen for 11C-clorgyline-D2 (31). (Adapted with permission of (31).)
|
|
Copyright © 2005 by the Society of Nuclear Medicine.